Hautkrebvorsorge bei Dr. Tatiana von Bayern in München

Skin cancer prevention

Skin cancer screening at dermatologist in Munich

The num­ber of skin can­cer cas­es has been increas­ing for decades. The “white” skin can­cers, basal cell car­ci­no­ma and squa­mous cell car­ci­no­ma, as well as black skin can­cer (malig­nant melanoma) togeth­er make up one of the most com­mon can­cers. If left untreat­ed, skin can­cer can be fatal. This can usu­al­ly be avoid­ed if the skin can­cer is diag­nosed in time. Close exam­i­na­tion by a med­ical spe­cial­ist at fixed time inter­vals can pre­vent skin can­cer or dis­cov­er it ear­ly.

The spec­trum of my ser­vices ranges from pre­ven­tive exam­i­na­tions with tis­sue removal and thor­ough his­to­log­i­cal eval­u­a­tion to sur­gi­cal and drug ther­a­py and skin can­cer after­care. Of spe­cial impor­tance are gen­tle and inno­v­a­tive ther­a­py con­cepts such as laser treat­ment and pho­to­dy­nam­ic ther­a­py in skin can­cer pre­cur­sors and surgery for skin can­cer that has already devel­oped. In the case of metasta­t­ic malig­nant melanoma, I work with spe­cialised der­ma­to-onco­log­i­cal cen­tres.

If you do have skin can­cer, I will cre­ate a guide­line-based after­care sched­ule for you.

My main focus on skin can­cer screen­ing also address­es organ trans­plant­ed and immune-sup­pressed patients. This is because peo­ple with these health con­di­tions have a sig­nif­i­cant­ly increased risk of devel­op­ing skin can­cer and need par­tic­u­lar­ly vig­i­lant der­ma­to-onco­log­i­cal sup­port at close inter­vals. I am hap­py to assist you and all oth­er patients need­ing med­ical treat­ment on the sub­ject of skin can­cer.

Mole checking

A spe­cial focus of my work as a der­ma­tol­o­gist with patients is the pre­ven­tion and ear­ly detec­tion of skin dis­eases. Skin can­cer screen­ing, in which I scan your skin all over the body square cen­time­tre by square cen­time­tre for skin lesions, is a key ser­vice in this regard.

There is a new inno­v­a­tive exam­i­na­tion pro­ce­dure that mea­sures and analy­ses moles using elec­tri­cal imped­ance spec­trom­e­try to detect changes in cell struc­ture, cell align­ment, cell size and cell types. This addi­tion­al infor­ma­tion is very valu­able in the diag­no­sis of melanomas and par­tic­u­lar­ly helps us in diag­nos­ing dif­fi­cult bor­der­line cas­es.

Actinic keratoses

In med­i­cine, we use the tech­ni­cal term actinic ker­ato­sis to describe a skin lesion that can lead to malig­nant skin can­cer. Actinic ker­atoses are pre-can­cer­ous lesions, i.e. skin can­cer pre­cur­sors, which must be diag­nosed and treat­ed with the utmost med­ical care.

Depend­ing on which areas are affect­ed, I can rec­om­mend dif­fer­ent types of ther­a­py. The spec­trum ranges from the removal of indi­vid­ual skin lesions with a laser or scalpel to the use of cold or a local cream appli­ca­tion. Very often, how­ev­er, there is a so-called field car­cino­geni­sa­tion. This means that mul­ti­ple actinic ker­atoses are present on a sur­face (e.g. décol­leté or bald head) at dif­fer­ent stages of matu­ri­ty. Pho­to­dy­nam­ic ther­a­py (PDT) has proven espe­cial­ly par­tic­u­lar­ly use­ful here.

Basal-cell carcinoma

Basal-cell car­ci­no­ma, also called basal-cell can­cer, belongs to the group of white or light skin can­cers and is the most com­mon skin can­cer in Cen­tral Europe. The good news for peo­ple suf­fer­ing from basal-cell car­ci­no­ma is that this form of skin can­cer can usu­al­ly be com­plete­ly cured by ear­ly detec­tion and rapid ther­a­py. I offer you proven exper­tise at my clin­ic for der­ma­tol­ogy in Munich and the nec­es­sary diag­nos­tic options.

I am at your side as a qual­i­fied der­ma­tol­o­gist and care­ful­ly select the appro­pri­ate form of treat­ment for diag­nos­ing basal-cell car­ci­no­ma. The type of basal-cell car­ci­no­ma (nodu­lar, scle­ro­der­mic, super­fi­cial), the size and local­i­sa­tion of the lesion as well as the age of the patient and his/her gen­er­al health sit­u­a­tion play a role. The nodu­lar and scle­ro­der­mic basal-cell car­ci­no­mas are usu­al­ly sur­gi­cal­ly removed.

The super­fi­cial trunk skin basal-cell car­ci­no­mas can be removed by laser if surgery is not desired or pos­si­ble. Alter­na­tive­ly, pho­to­dy­nam­ic ther­a­py is also used here. There­after, close mon­i­tor­ing of the skin at reg­u­lar inter­vals is par­tic­u­lar­ly impor­tant, since it can­not be guar­an­teed that the skin can­cer has been com­plete­ly removed.

Malignant melanoma

A malig­nant melanoma is one of the most dan­ger­ous skin tumours, also known as black skin can­cer due to its dark colour. In con­trast to white skin can­cer, black skin can­cer has the high­est metas­ta­sis rate and accounts for more than 90 per cent of all skin tumour deaths. There­fore, it is par­tic­u­lar­ly impor­tant to dis­cov­er the malig­nant melanoma as ear­ly as pos­si­ble and to ini­ti­ate the best pos­si­ble treat­ment.

In case of any clin­i­cal sus­pi­cion of a malig­nant melanoma this should always be removed sur­gi­cal­ly with a small safe­ty mar­gin. Depend­ing on the thick­ness of the tumour, it may be nec­es­sary to re-oper­ate accord­ing to guide­lines. I am there for you in my der­ma­tol­ogy clin­ic and offer skin can­cer screen­ing, surgery in case of sus­pect­ed malig­nant melanoma and tumour after­care as well as any con­cerns that arise from it.